Healthcare Svcs Group Inc Financials

HCSG

Source SEC Filings (10-K/10-Q) Updated Feb 13, 2026 Currency USD FYE February

This page shows Healthcare Svcs Group Inc (HCSG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 49/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Healthcare Svcs Group Inc has an operating margin of 3.9%, meaning the company retains $4 of operating profit per $100 of revenue. This below-average margin results in a low score of 20/100, suggesting thin profitability after operating expenses.

Growth

Healthcare Svcs Group Inc's revenue declined 99.9% year-over-year, from $1.7B to $1.8M. This contraction results in a growth score of 0/100.

Leverage

Healthcare Svcs Group Inc carries a low D/E ratio of 0.56, meaning only $0.56 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 90/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 3.38, Healthcare Svcs Group Inc holds $3.38 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

Healthcare Svcs Group Inc has a free cash flow margin of 7.6%, earning a moderate score of 38/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Healthcare Svcs Group Inc's ROE of 11.6% shows moderate profitability relative to equity, earning a score of 46/100. This is up from 7.9% the prior year.

Altman Z-Score Safe

3216.90

Healthcare Svcs Group Inc scores 3216.90, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.5B) relative to total liabilities ($284K). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Strong

7/9

Healthcare Svcs Group Inc passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

2.45x

For every $1 of reported earnings, Healthcare Svcs Group Inc generates $2.45 in operating cash flow ($145K OCF vs $59K net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Revenue

$1.8M

YoY-99.9%

5Y CAGR-74.7%

10Y CAGR-48.6%

Healthcare Svcs Group Inc generated $1.8M in revenue in fiscal year 2025. This represents a decrease of 99.9% from the prior year.

EBITDA

$89K

Healthcare Svcs Group Inc's EBITDA was $89K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Free Cash Flow

$139K

YoY-99.4%

5Y CAGR-76.9%

10Y CAGR-45.3%

Healthcare Svcs Group Inc generated $139K in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 99.4% from the prior year.

Net Income

$59K

YoY-99.9%

5Y CAGR-77.3%

10Y CAGR-49.8%

Healthcare Svcs Group Inc reported $59K in net income in fiscal year 2025. This represents a decrease of 99.9% from the prior year.

EPS (Diluted)

$0.81

YoY+52.8%

5Y CAGR-9.3%

10Y CAGR+0.1%

Healthcare Svcs Group Inc earned $0.81 per diluted share (EPS) in fiscal year 2025. This represents an increase of 52.8% from the prior year.

Cash & Debt

$125K

YoY-99.8%

5Y CAGR-75.4%

10Y CAGR-42.8%

Healthcare Svcs Group Inc held $125K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

70M

YoY-4.4%

5Y CAGR-1.2%

10Y CAGR-0.2%

Healthcare Svcs Group Inc had 70M shares outstanding in fiscal year 2025. This represents a decrease of 4.4% from the prior year.

Gross Margin

13.0%

YoY-0.3pp

5Y CAGR-2.2pp

Healthcare Svcs Group Inc's gross margin was 13.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.3 percentage points from the prior year.

Operating Margin

3.9%

Healthcare Svcs Group Inc's operating margin was 3.9% in fiscal year 2025, reflecting core business profitability.

Net Margin

3.2%

YoY+0.9pp

5Y CAGR-2.4pp

10Y CAGR-0.8pp

Healthcare Svcs Group Inc's net profit margin was 3.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.9 percentage points from the prior year.

Return on Equity

11.6%

YoY+3.7pp

5Y CAGR-9.4pp

10Y CAGR-8.0pp

Healthcare Svcs Group Inc's ROE was 11.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 3.7 percentage points from the prior year.

R&D Spending

N/A

Share Buybacks

$62K

YoY-98.8%

Healthcare Svcs Group Inc spent $62K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 98.8% from the prior year.

Capital Expenditures

$6K

YoY-99.9%

5Y CAGR-73.4%

10Y CAGR-49.1%

Healthcare Svcs Group Inc invested $6K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 99.9% from the prior year.

HCSG Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.8M-99.9%	$1.7B+2.7%	$1.7B-1.1%	$1.7B+2.9%	$1.6B-6.7%	$1.8B
Cost of Revenue	$1.6M-99.9%	$1.5B+2.1%	$1.5B-2.7%	$1.5B+6.1%	$1.4B-5.4%	$1.5B
Gross Profit	$239K-99.9%	$228.1M+6.2%	$214.7M+11.1%	$193.3M-16.2%	$230.6M-14.0%	$268.0M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$191K-99.9%	$183.1M+9.8%	$166.8M+18.8%	$140.3M-18.9%	$173.1M+14.8%	$150.8M
Operating Income	$72K	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$9K-99.9%	$13.5M-8.2%	$14.7M+42.3%	$10.3M-39.2%	$17.0M-44.4%	$30.5M
Net Income	$59K-99.9%	$39.5M+2.8%	$38.4M+12.1%	$34.2M-29.5%	$48.5M-50.8%	$98.7M
EPS (Diluted)	$0.81+52.8%	$0.53+1.9%	$0.52+13.0%	$0.46-29.2%	$0.65-50.8%	$1.32

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$466.7M+0.5%	$464.3M+1.3%	$458.5M+2.4%	$447.7M+2.2%	$437.8M+2.3%	$428.1M+0.4%	$426.3M+0.7%	$423.4M
Cost of Revenue	$394.6M+7.3%	$367.9M-19.2%	$455.5M+20.0%	$379.7M+0.1%	$379.2M+4.0%	$364.7M-5.2%	$384.7M+7.2%	$358.9M
Gross Profit	$72.1M-25.2%	$96.4M+3159.1%	$3.0M-95.6%	$68.0M+16.0%	$58.6M-7.6%	$63.4M+52.6%	$41.5M-35.6%	$64.5M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$46.2M-8.6%	$50.5M+2.8%	$49.2M+9.3%	$45.0M+0.3%	$44.8M-4.4%	$46.9M+5.5%	$44.4M-5.3%	$46.9M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	-$2.7M-118.8%	$14.4M+250.8%	-$9.5M-242.8%	$6.7M+131.1%	$2.9M-39.6%	$4.8M+2513.1%	-$198K-103.3%	$6.0M
Net Income	$31.2M-27.3%	$43.0M+232.7%	-$32.4M-287.9%	$17.2M+44.5%	$11.9M-15.0%	$14.0M+884.7%	-$1.8M-111.7%	$15.3M
EPS (Diluted)	$0.43-27.1%	$0.59+234.1%	$-0.44-291.3%	$0.23+53.3%	$0.15-21.1%	$0.19+1050.0%	$-0.02-109.5%	$0.21

HCSG Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$794K-99.9%	$802.8M+1.5%	$790.7M+9.7%	$720.8M-7.6%	$779.9M-0.7%	$785.0M
Current Assets	$576K-99.9%	$556.7M-2.6%	$571.7M+12.4%	$508.6M-6.9%	$546.4M-4.5%	$572.4M
Cash & Equivalents	$125K-99.8%	$56.8M+4.5%	$54.3M+106.7%	$26.3M-62.9%	$70.8M-49.2%	$139.3M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$281K-99.9%	$330.9M-4.0%	$344.9M	N/A	N/A	N/A
Goodwill	$80K-99.9%	$75.5M0.0%	$75.5M0.0%	$75.5M+1.0%	$74.8M+46.3%	$51.1M
Total Liabilities	$284K-99.9%	$302.8M-9.3%	$334.0M+10.4%	$302.6M-9.6%	$334.7M+6.3%	$314.8M
Current Liabilities	$170K-99.9%	$192.5M-11.2%	$216.9M+14.8%	$189.0M-1.1%	$191.1M+17.8%	$162.3M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$510K-99.9%	$499.9M+9.5%	$456.6M+9.2%	$418.3M-6.0%	$445.2M-5.3%	$470.3M
Retained Earnings	$284K-99.9%	$224.6M+21.4%	$185.0M+26.2%	$146.6M-20.3%	$184.0M-8.4%	$200.9M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$794.3M-1.2%	$804.3M+0.3%	$802.2M-2.5%	$823.0M+2.5%	$802.8M-0.4%	$805.8M+0.8%	$799.7M-0.5%	$803.9M
Current Assets	$576.4M-0.7%	$580.6M+9.1%	$532.3M-7.4%	$575.0M+3.3%	$556.7M-3.7%	$578.1M+0.9%	$573.2M-1.2%	$580.4M
Cash & Equivalents	$125.2M+0.6%	$124.4M+50.2%	$82.8M+28.8%	$64.3M+13.3%	$56.8M+109.9%	$27.1M+2.4%	$26.4M-9.8%	$29.3M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$281.3M-2.5%	$288.5M-1.3%	$292.2M-13.5%	$337.9M+2.1%	$330.9M	N/A	N/A	N/A
Goodwill	$79.8M-0.3%	$80.1M0.0%	$80.0M0.0%	$80.0M+6.0%	$75.5M0.0%	$75.5M0.0%	$75.5M0.0%	$75.5M
Total Liabilities	$284.0M-7.9%	$308.3M-5.2%	$325.2M+5.3%	$308.8M+2.0%	$302.8M-4.5%	$317.1M-3.4%	$328.3M-0.3%	$329.3M
Current Liabilities	$170.4M-12.9%	$195.6M-8.5%	$213.9M+7.6%	$198.7M+3.2%	$192.5M-2.4%	$197.2M-5.9%	$209.5M+0.1%	$209.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$510.2M+2.9%	$496.0M+4.0%	$477.0M-7.2%	$514.2M+2.9%	$499.9M+2.3%	$488.7M+3.7%	$471.4M-0.7%	$474.6M
Retained Earnings	$283.7M+12.4%	$252.4M+20.5%	$209.5M-13.4%	$241.8M+7.7%	$224.6M+5.6%	$212.6M+7.1%	$198.6M-0.9%	$200.4M

HCSG Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$145K-99.5%	$30.8M-29.2%	$43.5M+632.6%	-$8.2M-122.0%	$37.1M-82.9%	$217.2M
Capital Expenditures	$6K-99.9%	$6.3M+17.2%	$5.4M+3.8%	$5.2M-8.4%	$5.7M+31.0%	$4.3M
Free Cash Flow	$139K-99.4%	$24.5M-35.8%	$38.1M+384.8%	-$13.4M-142.6%	$31.4M-85.2%	$212.9M
Investing Cash Flow	$11K-99.8%	$6.0M+283.6%	-$3.3M-227.6%	$2.6M+111.2%	-$23.0M+37.6%	-$36.8M
Financing Cash Flow	$63K+100.2%	-$31.0M-155.5%	-$12.2M+68.8%	-$38.9M+52.9%	-$82.7M-20.9%	-$68.4M
Dividends Paid	N/A	$0	$0-100.0%	$63.4M+1.8%	$62.2M+2.5%	$60.7M
Share Buybacks	$62K-98.8%	$5.0M-55.5%	$11.3M	$0-100.0%	$21.5M	$0

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$17.4M-75.6%	$71.3M+147.7%	$28.8M+4.7%	$27.5M-24.0%	$36.2M+739.6%	$4.3M-73.6%	$16.3M+162.7%	-$26.0M
Capital Expenditures	$1.4M+3.3%	$1.3M-1.7%	$1.4M-22.0%	$1.7M+22.1%	$1.4M+2.0%	$1.4M+6.6%	$1.3M-40.3%	$2.2M
Free Cash Flow	$16.0M-77.1%	$70.0M+155.1%	$27.4M+6.5%	$25.8M-25.9%	$34.8M+1093.9%	$2.9M-80.6%	$15.0M+153.2%	-$28.2M
Investing Cash Flow	$8.6M+411.8%	-$2.7M-16.9%	-$2.4M+83.8%	-$14.5M-166.4%	$21.8M+7468.8%	$288K+101.0%	-$27.8M-336.9%	$11.7M
Financing Cash Flow	-$19.6M+28.1%	-$27.3M-255.3%	-$7.7M+12.6%	-$8.8M+66.2%	-$26.0M-332.9%	-$6.0M+53.8%	-$13.0M-193.1%	$14.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$19.6M-28.1%	$27.3M+255.3%	$7.7M+9.1%	$7.0M+596.6%	$1.0M+0.2%	$1.0M-66.4%	$3.0M	$0

HCSG Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	13.0%-0.3pp	13.3%+0.4pp	12.8%+1.4pp	11.4%-2.6pp	14.0%-1.2pp	15.2%
Operating Margin	3.9%	N/A	N/A	N/A	N/A	N/A
Net Margin	3.2%+0.9pp	2.3%0.0pp	2.3%+0.3pp	2.0%-0.9pp	3.0%-2.6pp	5.6%
Return on Equity	11.6%+3.7pp	7.9%-0.5pp	8.4%+0.2pp	8.2%-2.7pp	10.9%-10.1pp	21.0%
Return on Assets	7.4%+2.5pp	4.9%+0.1pp	4.9%+0.1pp	4.8%-1.5pp	6.2%-6.3pp	12.6%
Current Ratio	3.38+0.5	2.89+0.3	2.64-0.1	2.69-0.2	2.86-0.7	3.53
Debt-to-Equity	0.56-0.0	0.61-0.1	0.730.0	0.72-0.0	0.75+0.1	0.67
FCF Margin	7.6%+6.1pp	1.4%-0.9pp	2.3%+3.1pp	-0.8%-2.7pp	1.9%-10.2pp	12.1%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	15.4%-5.3pp	20.8%+20.1pp	0.7%-14.5pp	15.2%+1.8pp	13.4%-1.4pp	14.8%+5.1pp	9.8%-5.5pp	15.2%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	6.7%-2.6pp	9.3%+16.3pp	-7.1%-10.9pp	3.9%+1.1pp	2.7%-0.6pp	3.3%+3.7pp	-0.4%-4.0pp	3.6%
Return on Equity	6.1%-2.5pp	8.7%	N/A	3.4%+1.0pp	2.4%-0.5pp	2.9%	N/A	3.2%
Return on Assets	3.9%-1.4pp	5.3%+9.4pp	-4.0%-6.1pp	2.1%+0.6pp	1.5%-0.3pp	1.7%+2.0pp	-0.2%-2.1pp	1.9%
Current Ratio	3.38+0.4	2.97+0.5	2.49-0.4	2.890.0	2.89-0.0	2.93+0.2	2.74-0.0	2.77
Debt-to-Equity	0.56-0.1	0.62-0.1	0.68+0.1	0.600.0	0.61-0.0	0.65-0.0	0.700.0	0.69
FCF Margin	3.4%-11.6pp	15.1%+9.1pp	6.0%+0.2pp	5.8%-2.2pp	7.9%+7.3pp	0.7%-2.8pp	3.5%+10.2pp	-6.7%

Similar Companies

PACS Group PACS

$5.9B

U S Physical Therapy USPH

$1.3B

Pediatrix Medical Group, Inc. MD

$1.8B

Astrana Health ASTH

$941.9M

Aveanna Healthcare Holdings, Inc. AVAH

$1.7B

Frequently Asked Questions

What is Healthcare Svcs Group Inc's annual revenue?

Healthcare Svcs Group Inc (HCSG) reported $1.8M in total revenue for fiscal year 2025. This represents a -99.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Healthcare Svcs Group Inc's revenue growing?

Healthcare Svcs Group Inc (HCSG) revenue declined by 99.9% year-over-year, from $1.7B to $1.8M in fiscal year 2025.

Is Healthcare Svcs Group Inc profitable?

Yes, Healthcare Svcs Group Inc (HCSG) reported a net income of $59K in fiscal year 2025, with a net profit margin of 3.2%.

What is Healthcare Svcs Group Inc's earnings per share (EPS)?

Healthcare Svcs Group Inc (HCSG) reported diluted earnings per share of $0.81 for fiscal year 2025. This represents a 52.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Healthcare Svcs Group Inc's EBITDA?

Healthcare Svcs Group Inc (HCSG) had EBITDA of $89K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Healthcare Svcs Group Inc's gross margin?

Healthcare Svcs Group Inc (HCSG) had a gross margin of 13.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Healthcare Svcs Group Inc's operating margin?

Healthcare Svcs Group Inc (HCSG) had an operating margin of 3.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Healthcare Svcs Group Inc's net profit margin?

Healthcare Svcs Group Inc (HCSG) had a net profit margin of 3.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Healthcare Svcs Group Inc's return on equity (ROE)?

Healthcare Svcs Group Inc (HCSG) has a return on equity of 11.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Healthcare Svcs Group Inc's free cash flow?

Healthcare Svcs Group Inc (HCSG) generated $139K in free cash flow during fiscal year 2025. This represents a -99.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Healthcare Svcs Group Inc's operating cash flow?

Healthcare Svcs Group Inc (HCSG) generated $145K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Healthcare Svcs Group Inc's total assets?

Healthcare Svcs Group Inc (HCSG) had $794K in total assets as of fiscal year 2025, including both current and long-term assets.

What are Healthcare Svcs Group Inc's capital expenditures?

Healthcare Svcs Group Inc (HCSG) invested $6K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Healthcare Svcs Group Inc buy back shares?

Yes, Healthcare Svcs Group Inc (HCSG) spent $62K on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Healthcare Svcs Group Inc have outstanding?

Healthcare Svcs Group Inc (HCSG) had 70M shares outstanding as of fiscal year 2025.

What is Healthcare Svcs Group Inc's current ratio?

Healthcare Svcs Group Inc (HCSG) had a current ratio of 3.38 as of fiscal year 2025, which is generally considered healthy.

What is Healthcare Svcs Group Inc's debt-to-equity ratio?

Healthcare Svcs Group Inc (HCSG) had a debt-to-equity ratio of 0.56 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Healthcare Svcs Group Inc's return on assets (ROA)?

Healthcare Svcs Group Inc (HCSG) had a return on assets of 7.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Healthcare Svcs Group Inc's Altman Z-Score?

Healthcare Svcs Group Inc (HCSG) has an Altman Z-Score of 3216.90, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Healthcare Svcs Group Inc's Piotroski F-Score?

Healthcare Svcs Group Inc (HCSG) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Healthcare Svcs Group Inc's earnings high quality?

Healthcare Svcs Group Inc (HCSG) has an earnings quality ratio of 2.45x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Healthcare Svcs Group Inc?

Healthcare Svcs Group Inc (HCSG) scores 49 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.